Global AI Drug Development Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global AI Drug Development market size was valued at US$ million in 2023. With growing demand in downstream market, the AI Drug Development is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global AI Drug Development market. AI Drug Development are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of AI Drug Development. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the AI Drug Development market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on AI Drug Development market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the AI Drug Development market. It may include historical data, market segmentation by Type (e.g., Drug Design, Drug Synthesis), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the AI Drug Development market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the AI Drug Development market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the AI Drug Development industry. This include advancements in AI Drug Development technology, AI Drug Development new entrants, AI Drug Development new investment, and other innovations that are shaping the future of AI Drug Development.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the AI Drug Development market. It includes factors influencing customer ' purchasing decisions, preferences for AI Drug Development product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the AI Drug Development market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting AI Drug Development market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the AI Drug Development market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the AI Drug Development industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the AI Drug Development market.
Market Segmentation:
AI Drug Development market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global AI Drug Development market size was valued at US$ million in 2023. With growing demand in downstream market, the AI Drug Development is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global AI Drug Development market. AI Drug Development are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of AI Drug Development. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the AI Drug Development market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on AI Drug Development market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the AI Drug Development market. It may include historical data, market segmentation by Type (e.g., Drug Design, Drug Synthesis), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the AI Drug Development market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the AI Drug Development market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the AI Drug Development industry. This include advancements in AI Drug Development technology, AI Drug Development new entrants, AI Drug Development new investment, and other innovations that are shaping the future of AI Drug Development.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the AI Drug Development market. It includes factors influencing customer ' purchasing decisions, preferences for AI Drug Development product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the AI Drug Development market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting AI Drug Development market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the AI Drug Development market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the AI Drug Development industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the AI Drug Development market.
Market Segmentation:
AI Drug Development market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Drug Design
- Drug Synthesis
- Other
- Tumor
- Nervous System
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Insilico Medicine
- Cyclica
- XtalPi Inc.
- Exscientia Limited
- AiCure, LLC
- Atomwise
- Biovista Inc.
- Breg?Inc.
- Numerate
- Cloud Pharmaceuticals
- IBM
- NuMedii
- BenevolentAI
- Lam Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI Drug Development Market Size 2019-2030
2.1.2 AI Drug Development Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 AI Drug Development Segment by Type
2.2.1 Drug Design
2.2.2 Drug Synthesis
2.2.3 Other
2.3 AI Drug Development Market Size by Type
2.3.1 AI Drug Development Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI Drug Development Market Size Market Share by Type (2019-2024)
2.4 AI Drug Development Segment by Application
2.4.1 Tumor
2.4.2 Nervous System
2.4.3 Other
2.5 AI Drug Development Market Size by Application
2.5.1 AI Drug Development Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI Drug Development Market Size Market Share by Application (2019-2024)
3 AI DRUG DEVELOPMENT MARKET SIZE BY PLAYER
3.1 AI Drug Development Market Size Market Share by Players
3.1.1 Global AI Drug Development Revenue by Players (2019-2024)
3.1.2 Global AI Drug Development Revenue Market Share by Players (2019-2024)
3.2 Global AI Drug Development Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI DRUG DEVELOPMENT BY REGIONS
4.1 AI Drug Development Market Size by Regions (2019-2024)
4.2 Americas AI Drug Development Market Size Growth (2019-2024)
4.3 APAC AI Drug Development Market Size Growth (2019-2024)
4.4 Europe AI Drug Development Market Size Growth (2019-2024)
4.5 Middle East & Africa AI Drug Development Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas AI Drug Development Market Size by Country (2019-2024)
5.2 Americas AI Drug Development Market Size by Type (2019-2024)
5.3 Americas AI Drug Development Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI Drug Development Market Size by Region (2019-2024)
6.2 APAC AI Drug Development Market Size by Type (2019-2024)
6.3 APAC AI Drug Development Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI Drug Development by Country (2019-2024)
7.2 Europe AI Drug Development Market Size by Type (2019-2024)
7.3 Europe AI Drug Development Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI Drug Development by Region (2019-2024)
8.2 Middle East & Africa AI Drug Development Market Size by Type (2019-2024)
8.3 Middle East & Africa AI Drug Development Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI DRUG DEVELOPMENT MARKET FORECAST
10.1 Global AI Drug Development Forecast by Regions (2025-2030)
10.1.1 Global AI Drug Development Forecast by Regions (2025-2030)
10.1.2 Americas AI Drug Development Forecast
10.1.3 APAC AI Drug Development Forecast
10.1.4 Europe AI Drug Development Forecast
10.1.5 Middle East & Africa AI Drug Development Forecast
10.2 Americas AI Drug Development Forecast by Country (2025-2030)
10.2.1 United States AI Drug Development Market Forecast
10.2.2 Canada AI Drug Development Market Forecast
10.2.3 Mexico AI Drug Development Market Forecast
10.2.4 Brazil AI Drug Development Market Forecast
10.3 APAC AI Drug Development Forecast by Region (2025-2030)
10.3.1 China AI Drug Development Market Forecast
10.3.2 Japan AI Drug Development Market Forecast
10.3.3 Korea AI Drug Development Market Forecast
10.3.4 Southeast Asia AI Drug Development Market Forecast
10.3.5 India AI Drug Development Market Forecast
10.3.6 Australia AI Drug Development Market Forecast
10.4 Europe AI Drug Development Forecast by Country (2025-2030)
10.4.1 Germany AI Drug Development Market Forecast
10.4.2 France AI Drug Development Market Forecast
10.4.3 UK AI Drug Development Market Forecast
10.4.4 Italy AI Drug Development Market Forecast
10.4.5 Russia AI Drug Development Market Forecast
10.5 Middle East & Africa AI Drug Development Forecast by Region (2025-2030)
10.5.1 Egypt AI Drug Development Market Forecast
10.5.2 South Africa AI Drug Development Market Forecast
10.5.3 Israel AI Drug Development Market Forecast
10.5.4 Turkey AI Drug Development Market Forecast
10.5.5 GCC Countries AI Drug Development Market Forecast
10.6 Global AI Drug Development Forecast by Type (2025-2030)
10.7 Global AI Drug Development Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Information
11.1.2 Insilico Medicine AI Drug Development Product Offered
11.1.3 Insilico Medicine AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Insilico Medicine Main Business Overview
11.1.5 Insilico Medicine Latest Developments
11.2 Cyclica
11.2.1 Cyclica Company Information
11.2.2 Cyclica AI Drug Development Product Offered
11.2.3 Cyclica AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Cyclica Main Business Overview
11.2.5 Cyclica Latest Developments
11.3 XtalPi Inc.
11.3.1 XtalPi Inc. Company Information
11.3.2 XtalPi Inc. AI Drug Development Product Offered
11.3.3 XtalPi Inc. AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 XtalPi Inc. Main Business Overview
11.3.5 XtalPi Inc. Latest Developments
11.4 Exscientia Limited
11.4.1 Exscientia Limited Company Information
11.4.2 Exscientia Limited AI Drug Development Product Offered
11.4.3 Exscientia Limited AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Exscientia Limited Main Business Overview
11.4.5 Exscientia Limited Latest Developments
11.5 AiCure, LLC
11.5.1 AiCure, LLC Company Information
11.5.2 AiCure, LLC AI Drug Development Product Offered
11.5.3 AiCure, LLC AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AiCure, LLC Main Business Overview
11.5.5 AiCure, LLC Latest Developments
11.6 Atomwise
11.6.1 Atomwise Company Information
11.6.2 Atomwise AI Drug Development Product Offered
11.6.3 Atomwise AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Atomwise Main Business Overview
11.6.5 Atomwise Latest Developments
11.7 Biovista Inc.
11.7.1 Biovista Inc. Company Information
11.7.2 Biovista Inc. AI Drug Development Product Offered
11.7.3 Biovista Inc. AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biovista Inc. Main Business Overview
11.7.5 Biovista Inc. Latest Developments
11.8 Breg?Inc.
11.8.1 Breg?Inc. Company Information
11.8.2 Breg?Inc. AI Drug Development Product Offered
11.8.3 Breg?Inc. AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Breg?Inc. Main Business Overview
11.8.5 Breg?Inc. Latest Developments
11.9 Numerate
11.9.1 Numerate Company Information
11.9.2 Numerate AI Drug Development Product Offered
11.9.3 Numerate AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Numerate Main Business Overview
11.9.5 Numerate Latest Developments
11.10 Cloud Pharmaceuticals
11.10.1 Cloud Pharmaceuticals Company Information
11.10.2 Cloud Pharmaceuticals AI Drug Development Product Offered
11.10.3 Cloud Pharmaceuticals AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Cloud Pharmaceuticals Main Business Overview
11.10.5 Cloud Pharmaceuticals Latest Developments
11.11 IBM
11.11.1 IBM Company Information
11.11.2 IBM AI Drug Development Product Offered
11.11.3 IBM AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 IBM Main Business Overview
11.11.5 IBM Latest Developments
11.12 NuMedii
11.12.1 NuMedii Company Information
11.12.2 NuMedii AI Drug Development Product Offered
11.12.3 NuMedii AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 NuMedii Main Business Overview
11.12.5 NuMedii Latest Developments
11.13 BenevolentAI
11.13.1 BenevolentAI Company Information
11.13.2 BenevolentAI AI Drug Development Product Offered
11.13.3 BenevolentAI AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 BenevolentAI Main Business Overview
11.13.5 BenevolentAI Latest Developments
11.14 Lam Therapeutics
11.14.1 Lam Therapeutics Company Information
11.14.2 Lam Therapeutics AI Drug Development Product Offered
11.14.3 Lam Therapeutics AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Lam Therapeutics Main Business Overview
11.14.5 Lam Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. AI Drug Development Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Drug Design
Table 3. Major Players of Drug Synthesis
Table 4. Major Players of Other
Table 5. AI Drug Development Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global AI Drug Development Market Size byType (2019-2024) & ($ Millions)
Table 7. Global AI Drug Development Market Size Market Share byType (2019-2024)
Table 8. AI Drug Development Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global AI Drug Development Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global AI Drug Development Market Size Market Share by Application (2019-2024)
Table 11. Global AI Drug Development Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global AI Drug Development Revenue Market Share by Player (2019-2024)
Table 13. AI Drug Development Key Players Head office and Products Offered
Table 14. AI Drug Development Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global AI Drug Development Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global AI Drug Development Market Size Market Share by Regions (2019-2024)
Table 19. Global AI Drug Development Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global AI Drug Development Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas AI Drug Development Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas AI Drug Development Market Size Market Share by Country (2019-2024)
Table 23. Americas AI Drug Development Market Size byType (2019-2024) & ($ Millions)
Table 24. Americas AI Drug Development Market Size Market Share byType (2019-2024)
Table 25. Americas AI Drug Development Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas AI Drug Development Market Size Market Share by Application (2019-2024)
Table 27. APAC AI Drug Development Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC AI Drug Development Market Size Market Share by Region (2019-2024)
Table 29. APAC AI Drug Development Market Size byType (2019-2024) & ($ Millions)
Table 30. APAC AI Drug Development Market Size Market Share byType (2019-2024)
Table 31. APAC AI Drug Development Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC AI Drug Development Market Size Market Share by Application (2019-2024)
Table 33. Europe AI Drug Development Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe AI Drug Development Market Size Market Share by Country (2019-2024)
Table 35. Europe AI Drug Development Market Size byType (2019-2024) & ($ Millions)
Table 36. Europe AI Drug Development Market Size Market Share byType (2019-2024)
Table 37. Europe AI Drug Development Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe AI Drug Development Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa AI Drug Development Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa AI Drug Development Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa AI Drug Development Market Size byType (2019-2024) & ($ Millions)
Table 42. Middle East & Africa AI Drug Development Market Size Market Share byType (2019-2024)
Table 43. Middle East & Africa AI Drug Development Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa AI Drug Development Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of AI Drug Development
Table 46. Key Market Challenges & Risks of AI Drug Development
Table 47. Key IndustryTrends of AI Drug Development
Table 48. Global AI Drug Development Market SizeForecast by Regions (2025-2030) & ($ Millions)
Table 49. Global AI Drug Development Market Size Market ShareForecast by Regions (2025-2030)
Table 50. Global AI Drug Development Market SizeForecast byType (2025-2030) & ($ Millions)
Table 51. Global AI Drug Development Market SizeForecast by Application (2025-2030) & ($ Millions)
Table 52. Insilico Medicine Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 53. Insilico Medicine AI Drug Development Product Offered
Table 54. Insilico Medicine AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Insilico Medicine Main Business
Table 56. Insilico Medicine Latest Developments
Table 57. Cyclica Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 58. Cyclica AI Drug Development Product Offered
Table 59. Cyclica Main Business
Table 60. Cyclica AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Cyclica Latest Developments
Table 62. XtalPi Inc. Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 63. XtalPi Inc. AI Drug Development Product Offered
Table 64. XtalPi Inc. Main Business
Table 65. XtalPi Inc. AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. XtalPi Inc. Latest Developments
Table 67. Exscientia Limited Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 68. Exscientia Limited AI Drug Development Product Offered
Table 69. Exscientia Limited Main Business
Table 70. Exscientia Limited AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Exscientia Limited Latest Developments
Table 72. AiCure, LLC Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 73. AiCure, LLC AI Drug Development Product Offered
Table 74. AiCure, LLC Main Business
Table 75. AiCure, LLC AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. AiCure, LLC Latest Developments
Table 77. Atomwise Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 78. Atomwise AI Drug Development Product Offered
Table 79. Atomwise Main Business
Table 80. Atomwise AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Atomwise Latest Developments
Table 82. Biovista Inc. Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 83. Biovista Inc. AI Drug Development Product Offered
Table 84. Biovista Inc. Main Business
Table 85. Biovista Inc. AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Biovista Inc. Latest Developments
Table 87. Breg?Inc. Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 88. Breg?Inc. AI Drug Development Product Offered
Table 89. Breg?Inc. Main Business
Table 90. Breg?Inc. AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Breg?Inc. Latest Developments
Table 92. Numerate Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 93. Numerate AI Drug Development Product Offered
Table 94. Numerate Main Business
Table 95. Numerate AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Numerate Latest Developments
Table 97. Cloud Pharmaceuticals Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 98. Cloud Pharmaceuticals AI Drug Development Product Offered
Table 99. Cloud Pharmaceuticals Main Business
Table 100. Cloud Pharmaceuticals AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Cloud Pharmaceuticals Latest Developments
Table 102. IBM Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 103. IBM AI Drug Development Product Offered
Table 104. IBM AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. IBM Main Business
Table 106. IBM Latest Developments
Table 107. NuMedii Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 108. NuMedii AI Drug Development Product Offered
Table 109. NuMedii Main Business
Table 110. NuMedii AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. NuMedii Latest Developments
Table 112. BenevolentAI Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 113. BenevolentAI AI Drug Development Product Offered
Table 114. BenevolentAI Main Business
Table 115. BenevolentAI AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. BenevolentAI Latest Developments
Table 117. LamTherapeutics Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 118. LamTherapeutics AI Drug Development Product Offered
Table 119. LamTherapeutics Main Business
Table 120. LamTherapeutics AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. LamTherapeutics Latest Developments
LIST OFFIGURES
Figure 1. AI Drug Development Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI Drug Development Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. AI Drug Development Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. AI Drug Development Sales Market Share by Country/Region (2023)
Figure 8. AI Drug Development Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global AI Drug Development Market Size Market Share byType in 2023
Figure 10. AI Drug Development inTumor
Figure 11. Global AI Drug Development Market:Tumor (2019-2024) & ($ Millions)
Figure 12. AI Drug Development in Nervous System
Figure 13. Global AI Drug Development Market: Nervous System (2019-2024) & ($ Millions)
Figure 14. AI Drug Development in Other
Figure 15. Global AI Drug Development Market: Other (2019-2024) & ($ Millions)
Figure 16. Global AI Drug Development Market Size Market Share by Application in 2023
Figure 17. Global AI Drug Development Revenue Market Share by Player in 2023
Figure 18. Global AI Drug Development Market Size Market Share by Regions (2019-2024)
Figure 19. Americas AI Drug Development Market Size 2019-2024 ($ Millions)
Figure 20. APAC AI Drug Development Market Size 2019-2024 ($ Millions)
Figure 21. Europe AI Drug Development Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa AI Drug Development Market Size 2019-2024 ($ Millions)
Figure 23. Americas AI Drug Development Value Market Share by Country in 2023
Figure 24. United States AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC AI Drug Development Market Size Market Share by Region in 2023
Figure 29. APAC AI Drug Development Market Size Market Share byType in 2023
Figure 30. APAC AI Drug Development Market Size Market Share by Application in 2023
Figure 31. China AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 35. India AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe AI Drug Development Market Size Market Share by Country in 2023
Figure 38. Europe AI Drug Development Market Size Market Share byType (2019-2024)
Figure 39. Europe AI Drug Development Market Size Market Share by Application (2019-2024)
Figure 40. Germany AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 41.France AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa AI Drug Development Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa AI Drug Development Market Size Market Share byType (2019-2024)
Figure 47. Middle East & Africa AI Drug Development Market Size Market Share by Application (2019-2024)
Figure 48. Egypt AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 51.Turkey AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 54. APAC AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 55. Europe AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 57. United States AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 58. Canada AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 59. Mexico AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 60. Brazil AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 61. China AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 62. Japan AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 63. Korea AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 65. India AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 66. Australia AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 67. Germany AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 68.France AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 69. UK AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 70. Italy AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 71. Russia AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 72. Spain AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 73. Egypt AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 74. South Africa AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 75. Israel AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 76.Turkey AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 78. Global AI Drug Development Market Size Market ShareForecast byType (2025-2030)
Figure 79. Global AI Drug Development Market Size Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI Drug Development Market Size 2019-2030
2.1.2 AI Drug Development Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 AI Drug Development Segment by Type
2.2.1 Drug Design
2.2.2 Drug Synthesis
2.2.3 Other
2.3 AI Drug Development Market Size by Type
2.3.1 AI Drug Development Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI Drug Development Market Size Market Share by Type (2019-2024)
2.4 AI Drug Development Segment by Application
2.4.1 Tumor
2.4.2 Nervous System
2.4.3 Other
2.5 AI Drug Development Market Size by Application
2.5.1 AI Drug Development Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI Drug Development Market Size Market Share by Application (2019-2024)
3 AI DRUG DEVELOPMENT MARKET SIZE BY PLAYER
3.1 AI Drug Development Market Size Market Share by Players
3.1.1 Global AI Drug Development Revenue by Players (2019-2024)
3.1.2 Global AI Drug Development Revenue Market Share by Players (2019-2024)
3.2 Global AI Drug Development Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI DRUG DEVELOPMENT BY REGIONS
4.1 AI Drug Development Market Size by Regions (2019-2024)
4.2 Americas AI Drug Development Market Size Growth (2019-2024)
4.3 APAC AI Drug Development Market Size Growth (2019-2024)
4.4 Europe AI Drug Development Market Size Growth (2019-2024)
4.5 Middle East & Africa AI Drug Development Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas AI Drug Development Market Size by Country (2019-2024)
5.2 Americas AI Drug Development Market Size by Type (2019-2024)
5.3 Americas AI Drug Development Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI Drug Development Market Size by Region (2019-2024)
6.2 APAC AI Drug Development Market Size by Type (2019-2024)
6.3 APAC AI Drug Development Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI Drug Development by Country (2019-2024)
7.2 Europe AI Drug Development Market Size by Type (2019-2024)
7.3 Europe AI Drug Development Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI Drug Development by Region (2019-2024)
8.2 Middle East & Africa AI Drug Development Market Size by Type (2019-2024)
8.3 Middle East & Africa AI Drug Development Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI DRUG DEVELOPMENT MARKET FORECAST
10.1 Global AI Drug Development Forecast by Regions (2025-2030)
10.1.1 Global AI Drug Development Forecast by Regions (2025-2030)
10.1.2 Americas AI Drug Development Forecast
10.1.3 APAC AI Drug Development Forecast
10.1.4 Europe AI Drug Development Forecast
10.1.5 Middle East & Africa AI Drug Development Forecast
10.2 Americas AI Drug Development Forecast by Country (2025-2030)
10.2.1 United States AI Drug Development Market Forecast
10.2.2 Canada AI Drug Development Market Forecast
10.2.3 Mexico AI Drug Development Market Forecast
10.2.4 Brazil AI Drug Development Market Forecast
10.3 APAC AI Drug Development Forecast by Region (2025-2030)
10.3.1 China AI Drug Development Market Forecast
10.3.2 Japan AI Drug Development Market Forecast
10.3.3 Korea AI Drug Development Market Forecast
10.3.4 Southeast Asia AI Drug Development Market Forecast
10.3.5 India AI Drug Development Market Forecast
10.3.6 Australia AI Drug Development Market Forecast
10.4 Europe AI Drug Development Forecast by Country (2025-2030)
10.4.1 Germany AI Drug Development Market Forecast
10.4.2 France AI Drug Development Market Forecast
10.4.3 UK AI Drug Development Market Forecast
10.4.4 Italy AI Drug Development Market Forecast
10.4.5 Russia AI Drug Development Market Forecast
10.5 Middle East & Africa AI Drug Development Forecast by Region (2025-2030)
10.5.1 Egypt AI Drug Development Market Forecast
10.5.2 South Africa AI Drug Development Market Forecast
10.5.3 Israel AI Drug Development Market Forecast
10.5.4 Turkey AI Drug Development Market Forecast
10.5.5 GCC Countries AI Drug Development Market Forecast
10.6 Global AI Drug Development Forecast by Type (2025-2030)
10.7 Global AI Drug Development Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Information
11.1.2 Insilico Medicine AI Drug Development Product Offered
11.1.3 Insilico Medicine AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Insilico Medicine Main Business Overview
11.1.5 Insilico Medicine Latest Developments
11.2 Cyclica
11.2.1 Cyclica Company Information
11.2.2 Cyclica AI Drug Development Product Offered
11.2.3 Cyclica AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Cyclica Main Business Overview
11.2.5 Cyclica Latest Developments
11.3 XtalPi Inc.
11.3.1 XtalPi Inc. Company Information
11.3.2 XtalPi Inc. AI Drug Development Product Offered
11.3.3 XtalPi Inc. AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 XtalPi Inc. Main Business Overview
11.3.5 XtalPi Inc. Latest Developments
11.4 Exscientia Limited
11.4.1 Exscientia Limited Company Information
11.4.2 Exscientia Limited AI Drug Development Product Offered
11.4.3 Exscientia Limited AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Exscientia Limited Main Business Overview
11.4.5 Exscientia Limited Latest Developments
11.5 AiCure, LLC
11.5.1 AiCure, LLC Company Information
11.5.2 AiCure, LLC AI Drug Development Product Offered
11.5.3 AiCure, LLC AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AiCure, LLC Main Business Overview
11.5.5 AiCure, LLC Latest Developments
11.6 Atomwise
11.6.1 Atomwise Company Information
11.6.2 Atomwise AI Drug Development Product Offered
11.6.3 Atomwise AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Atomwise Main Business Overview
11.6.5 Atomwise Latest Developments
11.7 Biovista Inc.
11.7.1 Biovista Inc. Company Information
11.7.2 Biovista Inc. AI Drug Development Product Offered
11.7.3 Biovista Inc. AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biovista Inc. Main Business Overview
11.7.5 Biovista Inc. Latest Developments
11.8 Breg?Inc.
11.8.1 Breg?Inc. Company Information
11.8.2 Breg?Inc. AI Drug Development Product Offered
11.8.3 Breg?Inc. AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Breg?Inc. Main Business Overview
11.8.5 Breg?Inc. Latest Developments
11.9 Numerate
11.9.1 Numerate Company Information
11.9.2 Numerate AI Drug Development Product Offered
11.9.3 Numerate AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Numerate Main Business Overview
11.9.5 Numerate Latest Developments
11.10 Cloud Pharmaceuticals
11.10.1 Cloud Pharmaceuticals Company Information
11.10.2 Cloud Pharmaceuticals AI Drug Development Product Offered
11.10.3 Cloud Pharmaceuticals AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Cloud Pharmaceuticals Main Business Overview
11.10.5 Cloud Pharmaceuticals Latest Developments
11.11 IBM
11.11.1 IBM Company Information
11.11.2 IBM AI Drug Development Product Offered
11.11.3 IBM AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 IBM Main Business Overview
11.11.5 IBM Latest Developments
11.12 NuMedii
11.12.1 NuMedii Company Information
11.12.2 NuMedii AI Drug Development Product Offered
11.12.3 NuMedii AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 NuMedii Main Business Overview
11.12.5 NuMedii Latest Developments
11.13 BenevolentAI
11.13.1 BenevolentAI Company Information
11.13.2 BenevolentAI AI Drug Development Product Offered
11.13.3 BenevolentAI AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 BenevolentAI Main Business Overview
11.13.5 BenevolentAI Latest Developments
11.14 Lam Therapeutics
11.14.1 Lam Therapeutics Company Information
11.14.2 Lam Therapeutics AI Drug Development Product Offered
11.14.3 Lam Therapeutics AI Drug Development Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Lam Therapeutics Main Business Overview
11.14.5 Lam Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. AI Drug Development Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Drug Design
Table 3. Major Players of Drug Synthesis
Table 4. Major Players of Other
Table 5. AI Drug Development Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global AI Drug Development Market Size byType (2019-2024) & ($ Millions)
Table 7. Global AI Drug Development Market Size Market Share byType (2019-2024)
Table 8. AI Drug Development Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global AI Drug Development Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global AI Drug Development Market Size Market Share by Application (2019-2024)
Table 11. Global AI Drug Development Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global AI Drug Development Revenue Market Share by Player (2019-2024)
Table 13. AI Drug Development Key Players Head office and Products Offered
Table 14. AI Drug Development Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global AI Drug Development Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global AI Drug Development Market Size Market Share by Regions (2019-2024)
Table 19. Global AI Drug Development Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global AI Drug Development Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas AI Drug Development Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas AI Drug Development Market Size Market Share by Country (2019-2024)
Table 23. Americas AI Drug Development Market Size byType (2019-2024) & ($ Millions)
Table 24. Americas AI Drug Development Market Size Market Share byType (2019-2024)
Table 25. Americas AI Drug Development Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas AI Drug Development Market Size Market Share by Application (2019-2024)
Table 27. APAC AI Drug Development Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC AI Drug Development Market Size Market Share by Region (2019-2024)
Table 29. APAC AI Drug Development Market Size byType (2019-2024) & ($ Millions)
Table 30. APAC AI Drug Development Market Size Market Share byType (2019-2024)
Table 31. APAC AI Drug Development Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC AI Drug Development Market Size Market Share by Application (2019-2024)
Table 33. Europe AI Drug Development Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe AI Drug Development Market Size Market Share by Country (2019-2024)
Table 35. Europe AI Drug Development Market Size byType (2019-2024) & ($ Millions)
Table 36. Europe AI Drug Development Market Size Market Share byType (2019-2024)
Table 37. Europe AI Drug Development Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe AI Drug Development Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa AI Drug Development Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa AI Drug Development Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa AI Drug Development Market Size byType (2019-2024) & ($ Millions)
Table 42. Middle East & Africa AI Drug Development Market Size Market Share byType (2019-2024)
Table 43. Middle East & Africa AI Drug Development Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa AI Drug Development Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of AI Drug Development
Table 46. Key Market Challenges & Risks of AI Drug Development
Table 47. Key IndustryTrends of AI Drug Development
Table 48. Global AI Drug Development Market SizeForecast by Regions (2025-2030) & ($ Millions)
Table 49. Global AI Drug Development Market Size Market ShareForecast by Regions (2025-2030)
Table 50. Global AI Drug Development Market SizeForecast byType (2025-2030) & ($ Millions)
Table 51. Global AI Drug Development Market SizeForecast by Application (2025-2030) & ($ Millions)
Table 52. Insilico Medicine Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 53. Insilico Medicine AI Drug Development Product Offered
Table 54. Insilico Medicine AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Insilico Medicine Main Business
Table 56. Insilico Medicine Latest Developments
Table 57. Cyclica Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 58. Cyclica AI Drug Development Product Offered
Table 59. Cyclica Main Business
Table 60. Cyclica AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Cyclica Latest Developments
Table 62. XtalPi Inc. Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 63. XtalPi Inc. AI Drug Development Product Offered
Table 64. XtalPi Inc. Main Business
Table 65. XtalPi Inc. AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. XtalPi Inc. Latest Developments
Table 67. Exscientia Limited Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 68. Exscientia Limited AI Drug Development Product Offered
Table 69. Exscientia Limited Main Business
Table 70. Exscientia Limited AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Exscientia Limited Latest Developments
Table 72. AiCure, LLC Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 73. AiCure, LLC AI Drug Development Product Offered
Table 74. AiCure, LLC Main Business
Table 75. AiCure, LLC AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. AiCure, LLC Latest Developments
Table 77. Atomwise Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 78. Atomwise AI Drug Development Product Offered
Table 79. Atomwise Main Business
Table 80. Atomwise AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Atomwise Latest Developments
Table 82. Biovista Inc. Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 83. Biovista Inc. AI Drug Development Product Offered
Table 84. Biovista Inc. Main Business
Table 85. Biovista Inc. AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Biovista Inc. Latest Developments
Table 87. Breg?Inc. Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 88. Breg?Inc. AI Drug Development Product Offered
Table 89. Breg?Inc. Main Business
Table 90. Breg?Inc. AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Breg?Inc. Latest Developments
Table 92. Numerate Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 93. Numerate AI Drug Development Product Offered
Table 94. Numerate Main Business
Table 95. Numerate AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Numerate Latest Developments
Table 97. Cloud Pharmaceuticals Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 98. Cloud Pharmaceuticals AI Drug Development Product Offered
Table 99. Cloud Pharmaceuticals Main Business
Table 100. Cloud Pharmaceuticals AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Cloud Pharmaceuticals Latest Developments
Table 102. IBM Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 103. IBM AI Drug Development Product Offered
Table 104. IBM AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. IBM Main Business
Table 106. IBM Latest Developments
Table 107. NuMedii Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 108. NuMedii AI Drug Development Product Offered
Table 109. NuMedii Main Business
Table 110. NuMedii AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. NuMedii Latest Developments
Table 112. BenevolentAI Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 113. BenevolentAI AI Drug Development Product Offered
Table 114. BenevolentAI Main Business
Table 115. BenevolentAI AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. BenevolentAI Latest Developments
Table 117. LamTherapeutics Details, CompanyType, AI Drug Development Area Served and Its Competitors
Table 118. LamTherapeutics AI Drug Development Product Offered
Table 119. LamTherapeutics Main Business
Table 120. LamTherapeutics AI Drug Development Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. LamTherapeutics Latest Developments
LIST OFFIGURES
Figure 1. AI Drug Development Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI Drug Development Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. AI Drug Development Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. AI Drug Development Sales Market Share by Country/Region (2023)
Figure 8. AI Drug Development Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global AI Drug Development Market Size Market Share byType in 2023
Figure 10. AI Drug Development inTumor
Figure 11. Global AI Drug Development Market:Tumor (2019-2024) & ($ Millions)
Figure 12. AI Drug Development in Nervous System
Figure 13. Global AI Drug Development Market: Nervous System (2019-2024) & ($ Millions)
Figure 14. AI Drug Development in Other
Figure 15. Global AI Drug Development Market: Other (2019-2024) & ($ Millions)
Figure 16. Global AI Drug Development Market Size Market Share by Application in 2023
Figure 17. Global AI Drug Development Revenue Market Share by Player in 2023
Figure 18. Global AI Drug Development Market Size Market Share by Regions (2019-2024)
Figure 19. Americas AI Drug Development Market Size 2019-2024 ($ Millions)
Figure 20. APAC AI Drug Development Market Size 2019-2024 ($ Millions)
Figure 21. Europe AI Drug Development Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa AI Drug Development Market Size 2019-2024 ($ Millions)
Figure 23. Americas AI Drug Development Value Market Share by Country in 2023
Figure 24. United States AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC AI Drug Development Market Size Market Share by Region in 2023
Figure 29. APAC AI Drug Development Market Size Market Share byType in 2023
Figure 30. APAC AI Drug Development Market Size Market Share by Application in 2023
Figure 31. China AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 35. India AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe AI Drug Development Market Size Market Share by Country in 2023
Figure 38. Europe AI Drug Development Market Size Market Share byType (2019-2024)
Figure 39. Europe AI Drug Development Market Size Market Share by Application (2019-2024)
Figure 40. Germany AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 41.France AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa AI Drug Development Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa AI Drug Development Market Size Market Share byType (2019-2024)
Figure 47. Middle East & Africa AI Drug Development Market Size Market Share by Application (2019-2024)
Figure 48. Egypt AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 51.Turkey AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country AI Drug Development Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 54. APAC AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 55. Europe AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 57. United States AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 58. Canada AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 59. Mexico AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 60. Brazil AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 61. China AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 62. Japan AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 63. Korea AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 65. India AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 66. Australia AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 67. Germany AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 68.France AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 69. UK AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 70. Italy AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 71. Russia AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 72. Spain AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 73. Egypt AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 74. South Africa AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 75. Israel AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 76.Turkey AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries AI Drug Development Market Size 2025-2030 ($ Millions)
Figure 78. Global AI Drug Development Market Size Market ShareForecast byType (2025-2030)
Figure 79. Global AI Drug Development Market Size Market ShareForecast by Application (2025-2030)
More Publications
Global Air Cargo Management Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
106 pages
Global Railway Back Office Outsourcing Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
87 pages
Global Quality Control Software Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
111 pages
Global Employee Attendance Tracker Market Growth (Status and Outlook) 2026-2032
US$ 3,660.00
June 2026
151 pages
Global Class-D Audio Power Amplifiers Market Growth 2025-2031
US$ 3,660.00
November 2025
142 pages
